The US may use “trade tools” to retaliate against European ESG regulations that affect American companies, said Howard ...

Howard Lutnick said he thought it was a “perfectly reasonable thing to do” to implement DEI policies — a stark ...

Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...

ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.

Lyft reported strong gross bookings and revenue growth but both missed expectations. The company's performance is being impacted by a challenging pricing environment and competition.